Ninian N. Lang MB ChB, PhDProfessor of Cardiology and Cardio-Oncology, School of Cardiovascular and Metabolic Health, University of Glasgow, Scotland, United Kingdom
Ninian Lang is Professor of Cardiology and Cardio-Oncology at the University of Glasgow. He serves as an Honorary Consultant Cardiologist at the Queen Elizabeth University Hospital and the Beatson West of Scotland Cancer Centre. His clinical and academic work focuses on cardio-oncology and heart failure. He is a Fellow of the Royal College of Physicians (Edinburgh) and of the European Society of Cardiology. He is an Associate Editor of the JACC:CardioOncology.
Ninian Lang was a co-author of the Cardiac CARE trial which was funded by a Medical Research Council and NIHR partnership, and the British Heart Foundation (15/48/20). He is supported by a British Heart Foundation Centre of Research excellence award (RE/18/6/34217). He has received personal fees from Akero, Roche, Pfizer, Jazz Pharma, CV6 Therapeutics and Novartis and research grant support from Roche Diagnostics, Boehringer Ingelheim and Astra Zeneca all administered by his employer (The University of Glasgow), all outside the submitted work.